Vikas Lifecare Intrinsic Value
Vikas Lifecare intrinsic value. Vikas Lifecare (VIKASLIFE) median intrinsic value is ₹3.60 from 8 valuation models (range ₹2–₹4), vs current price ₹1.20 — +200.0% upside (Trading Below Calculated Value), margin of safety 66.7%. For current market price and key ratios, visit Vikas Lifecare share price screener.
VIKASLIFE Valuation Methods Summary — DCF, Graham Number & P/E
Vikas Lifecare intrinsic value across 8 models vs current price ₹1.20 — upside/downside and value range per method. Read Vikas Lifecare dividend payments for the complete payout history and dividend yield track record.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹3.60 | ₹2.88 - ₹4.32 | +200.0% | EPS: ₹0.88, Sector P/E: 12x |
| Book Value Method | asset | ₹3.00 | ₹2.70 - ₹3.30 | +150.0% | Book Value/Share: ₹29.68, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹2.40 | ₹2.16 - ₹2.64 | +100.0% | Revenue/Share: ₹50.11, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹2.40 | ₹2.16 - ₹2.64 | +100.0% | EBITDA: ₹152.00Cr, EV/EBITDA: 6x |
| PEG Ratio Method | growth | ₹3.60 | ₹3.24 - ₹3.96 | +200.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹3.60 | ₹3.24 - ₹3.96 | +200.0% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹2.40 | ₹2.16 - ₹2.64 | +100.0% | ROE: 30.4%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹3.60 | ₹3.24 - ₹3.96 | +200.0% | EPS: ₹0.88, BVPS: ₹29.68 |
VIKASLIFE Intrinsic Value vs Market Price — All Valuation Models
Vikas Lifecare fair value range ₹2–₹4 vs current market price ₹1.20 across 8 valuation models. Compare with VIKASLIFE DCF valuation to assess whether the stock is under or overvalued.
VIKASLIFE Intrinsic Value Analysis — Undervalued or Overvalued?
Vikas Lifecare median intrinsic value ₹3.60, current price ₹1.20 — Trading Below Calculated Value by 200.0%, margin of safety 66.7%.
What is the intrinsic value of VIKASLIFE?
Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of Vikas Lifecare (VIKASLIFE) is ₹3.60 (median value). With the current market price of ₹1.20, this represents a +200.0% variance from our estimated fair value.
The valuation range spans from ₹2.40 to ₹3.60, indicating ₹2.40 - ₹3.60.
Is VIKASLIFE undervalued or overvalued?
Based on our multi-method analysis, Vikas Lifecare (VIKASLIFE) appears to be trading below calculated value by approximately 200.0%.
VIKASLIFE Financial Health — Key Ratios vs Industry Benchmarks
Vikas Lifecare financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 5.12 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 30.4% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | -16.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.23x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
VIKASLIFE Cash Flow Quality — Operating & Free Cash Flow
Vikas Lifecare operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-222 Cr | ₹-222 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹-42 Cr | ₹-88 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹-112 Cr | ₹-131 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹-15 Cr | ₹-34 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹-8 Cr | ₹-8 Cr | Negative Cash Flow | 3/10 |